FDA Globalization Act of 2009
This article was originally published in The Rose Sheet
Rep John Dingell, D-Mich., former Energy and Commerce Committee chairman, has revived his proposal for sweeping regulatory and import safety reforms amid a recent flurry of recalls related to salmonella-contaminated peanut butter, according to a Jan. 28 release. Although the latest food contamination outbreak - which has sickened nearly 500 people and been linked to eight deaths - is emphasized most in the sponsors' remarks, the bill seeks to equip FDA with appropriate funding and authority for regulating not only food but drugs, devices and cosmetics as well. Similar to the version that circulated in draft form in 2008, the bill would require cosmetic manufacturers to register their facilities with FDA, submit ingredient statements and report serious and unexpected adverse events (1"The Rose Sheet" April 21, 2008, p. 4). Rep. Frank Pallone, D-N.J., chairman of the Health subcommittee and a recognized ally of the dietary supplement industry, and Dingell protégé Rep. Bart Stupak, D- Mich., who chairs the Oversight and Investigations subcommittee, are co-sponsors of the bill. While some experts believe the focus of the 111 Congress will be on economic and health-care issues, "the fact that Dingell, Stupak and Pallone are all on the bill means that this is a top priority," according to John Manthei, a food and drug attorney at Latham & Watkins and former Energy and Commerce majority counsel
Sign in to continue reading.
New to HBW Insight?
Start a free trial today!
Register for our free email digests: